P0038, P0039, LAY USER INSTRUCTIONS 

P0040, P0041 

COVID-19 Rapid Antigen 

At-Home Test

FOR EMERGENCY USE AUTHORIZATION 

(EUA) ONLY IN VITRO DIAGNOSTIC USE ONLY

Read all instructions carefully before performing the test. Failure to follow the 

instructions may result in inaccurate test results. 

• An anterior nasal swab sample can be self-collected by an individual aged 14 

years and older. Children aged 2 to 13 years should be tested by an adult. 

• For the most current information on COVID-19, please visit: 

www.cdc.gov/COVID19. 

KIT CONTENTS 

1 2 

3 4 

INDICAID COVID-19 Rapid Antigen Test 

TEST DEVICE 

1. Individually wrapped sterile nasal swab 4. Quick reference guide (see reverse side) 

2. Single use buffer solution vial 5. Lay user instructions (this document) 

3. Individually packaged single-use 

test device 

NOTE: This product comes in a 2-test, 4-test, 12-test, or 24-test format. The 

number of items supplied in the kit will vary depending on which kit was 

purchased. 

A timer is required to perform the test and is not included in the test kit. 

Do not begin if you do not have at least 25 minutes available to focus on 

performing the test. Before you begin, wash your hands for at least 20 seconds 

and then dry your hands. Perform the test indoors, at room temperature on a 

clean, flat surface.

INTENDED USE 

The INDICAIDTM COVID-19 Rapid Antigen At-Home Test is a lateral flow 

immunoassay device intended for the qualitative detection of SARS-CoV-2 

virus. This test is authorized for non-prescription home use with self-collected 

anterior nasal (nares) swab samples from individuals aged 14 years or older, or 

adult-collected anterior nasal (nares) swab samples from individuals aged 2 

years or older. This test is authorized for individuals with symptoms of COVID-19 

within the first 6 days of symptom onset when tested at least twice over 

three days with at least 48 hours between tests, and for individuals without 

symptoms or other epidemiological reasons to suspect COVID-19, when tested 

at least three times over five days with at least 48 hours between tests.

The INDICAIDTM COVID-19 Rapid Antigen At-Home Test does not differentiate 

between SARS-CoV and SARS-CoV-2 viruses. 

Results are for the identification of SARS-CoV-2 nucleocapsid protein antigen 

which is generally detectable in anterior nasal (nares) swabs during the acute 

phase of infection. Positive results indicate the presence of viral antigens, but 

clinical correlation with past medical history and other diagnostic information 

is necessary to determine infection status. Positive results do not rule out 

bacterial infection or co-infection with other viruses and the agent detected 

may not be the definite cause of disease. Individuals who test positive with the 

INDICAIDTM COVID-19 Rapid Antigen At-Home Test should self-isolate and seek 

follow-up care with their physician or healthcare provider as additional testing 

may be necessary. 

All negative results are presumptive and confirmation with a molecular assay, 

if necessary for patient management, may be performed. Negative results 

do not rule out SARS-CoV-2 infection and should not be used as the sole 

basis for treatment or patient management decisions, including infection 

control measures such as isolating from other and wearing masks. Negative 

results should be considered in the context of a patient’s recent exposures, 

history, and the presence of clinical signs and symptoms consistent with 

COVID-19. Individuals who test negative and continue to experience COVID-19 

like symptoms of fever, cough, and/or shortness of breath may still have 

SARS-CoV-2 infection and should seek follow up care with their physician or 

healthcare provider. 

Individuals should provide all results obtained with this product to their 

healthcare provider for public health reporting and to receive appropriate 

medical care. All healthcare providers will report all test results they receive 

from individuals who use the authorized product to relevant public health 

authorities in accordance with local, state, and federal requirements using 

appropriate LOINC and SNOMED codes, as defined by the Laboratory In Vitro 

Diagnostics (LIVD) Test Code Mapping for SARS-CoV-2 Tests provided by CDC. 

The INDICAIDTM COVID-19 Rapid Antigen At-Home Test is intended for nonprescription self-use and/or as applicable, for an adult lay user testing another 

aged 2 years or older in a non-laboratory setting. The INDICAIDTM COVID-19 

Rapid Antigen At-Home Test is only for in vitro diagnostic use under the Food 

and Drug Administration’s Emergency Use Authorization. This product has not 

been FDA cleared or approved. 

WARNINGS, PRECAUTIONS, AND SAFETY INFORMATION 

• Read all instructions carefully before performing the test. Failure to follow 

the instructions may result in inaccurate test results 

• In the USA, this product has not been FDA cleared or approved but has been 

authorized by FDA under an Emergency Use Authorization (EUA). 

• This product has been authorized only for the detection of proteins from 

SARS-CoV-2, not for any other viruses or pathogens. 

• The emergency use of this product is only authorized for the duration of 

the declaration that circumstances exist justifying the authorization of 

emergency use of in vitro diagnostics for detection and/or diagnosis of 

COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic 

Act, 21 U.S.C. §360bbb3(b)(1), unless the declaration is terminated, or 

authorization is revoked sooner. 

• Serial testing should be performed in individuals with negative results 

at least twice over three days (with 48 hours between tests) for 

symptomatic individuals and three times over five days (with at least 

48 hours between tests) for asymptomatic individuals. You may need to 

purchase additional tests to perform this serial (repeat) testing. 

• If you have had symptoms longer than 6 days you should consider testing at 

least three times over five days with at least 48 hours between tests.

• Leave test card sealed in its pouch until just before use. Once opened, 

the test card should be used within 2 hours. 

• Do not touch swab tip. 

• Use only the contents provided in the test kit. 

• Test components are single use. Do not re-use. 

• Do not use if any of the test kit contents or packaging is damaged or open. 

• Keep testing kit and kit components away from children and pets before and 

after use. Avoid contact with your skin, eyes, nose, or mouth. Do not ingest 

any kit components. The reagent solution contains harmful chemicals (see 

table below). If contact to the body occurs, flush with large amounts of water. 

If irritation persists, seek medical advice: https://www.poisonhelp.org or 

1-800-222-1222. 

• Do not use the test on children under 2 years of age. 

• Children aged 2 to 13 years of age should be tested by an adult. 

• Wear a safety mask or other face covering when collecting specimen from a 

child or another individual. 

• False negative test results may occur if a specimen is incorrectly collected or 

handled. 

• Keep foreign substances and household cleaning products away from 

the test during the testing process. Contact with foreign substances and 

household cleaning products (e.g., 1% bleach) may result in an incorrect test 

result. 

• Do not read test results before 20 minutes or after 25 minutes. Results read 

before 20 minutes or after 25 minutes may lead to a false positive, false 

negative, or invalid result. 

• Do not use this test kit beyond its expiration date. For more information on 

expiration dating for COVID-19 antigen tests, please refer to 

http://www.fda.gov/covid-tests 

HAZARDOUS INGREDIENTS 

LIMITATIONS 

There is a higher chance of false negative results with antigen tests than with 

laboratory-based molecular tests due to the sensitivity of the test technology. 

This means that there is a higher chance this test will give a false negative 

result in an individual with COVID-19 as compared to a molecular test, 

especially in samples with low viral load. 

The performance of this test was established based on the evaluation of a limited 

number of clinical specimens collected between December 2021 and January 

2022. The clinical performance has not been established for all circulating variants 

but is anticipated to be reflective of the prevalent variants in circulation at the

time and location of the clinical evaluation. Performance at the time of testing 

may vary depending on the variants circulating, including newly emerging strains 

of SARS-CoV-2 and their prevalence, which change over time. 

All COVID-19 antigen test negative results are presumptive and confirmation 

with a molecular assay may be necessary. If you continue to have symptoms of 

COVID-19, and both your first and second tests are negative, you may not have 

COVID-19, however you should follow-up with a healthcare provider. 

If the test is positive, then proteins from the virus that causes COVID-19 have 

been found in your sample and you likely have COVID-19. 

This test is read visually and has not been validated for use by those with 

impaired vision or color-impaired vision. 

Incorrect test results may occur if a specimen is incorrectly collected or handled. 

FREQUENTLY ASKED QUESTIONS 

Will this test hurt? 

No. The nasal swab is not sharp and it should not hurt. Sometimes the swab 

can feel slightly uncomfortable. If you feel pain, please stop the test and seek 

advice from a healthcare provider. 

What is COVID-19? 

COVID-19 is caused by the SARS-CoV-2 virus which is a new virus in humans 

causing a contagious respiratory illness. COVID-19 can present with a mild to 

severe illness, although some people infected with COVID-19 may have no 

symptoms at all. Older adults and people of any age who have underlying 

medical conditions have a higher risk of severe illness from COVID-19. Serious 

outcomes of COVID-19 include hospitalization and death. The SARS-CoV-2 

virus can be spread to others not just while one is sick, but even before 

a person shows signs or symptoms of being sick (e.g., fever, coughing, 

difficulty breathing, etc.). A full list of symptoms of COVID-19 can be found at 

the following link: www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/ 

symptoms.html. 

What is serial testing? 

Serial testing is when one person tests themselves multiple times for COVID-19 

on a routine basis, such as every day or every other day. By testing more 

frequently, you may detect COVID-19 more quickly and reduce spread of 

infection. Please see the Warnings, Precautions, and Safety Information section 

for the recommended testing frequency for individuals with and without 

symptoms of COVID-19. 

What are the known and potential risks and benefits of the test?

Potential risks include: 

• Possible discomfort during sample collection. 

• Possible incorrect results (see Warnings, Precautions, and Safety Information 

and Interpreting Your Results sections for more information). 

Benefits include:

• The results, along with other information, can help you and your healthcare 

provider make informed recommendations about your care. 

• The results of this test may help limit the potential spread of COVID-19 to 

your family and others in your community. 

For more information on EUAs visit: www.fda.gov/emergency-preparednessand-response/mcm-legal-regulatory-and-policy-framework/emergency-useauthorization. 

What is the difference between an antigen and molecular test? 

There are different kinds of tests for the virus that causes COVID-19. Molecular 

tests detect genetic material from the virus. Antigen tests, such as the 

INDICAIDTM COVID-19 Rapid Antigen At-Home Test, detect proteins from the 

virus. Due to the lower sensitivity of antigen tests, there is a higher chance 

this test will give you a false negative result when you have COVID-19 than a 

molecular test would. 

How accurate is this test?

Clinical studies have shown that antigen tests more accurately determine 

whether you are infected with the virus that causes COVID-19 when taken 

multiple times across several days. Repeat testing improves test accuracy. 

This serial testing approach is recommended to minimize the risk of incorrect 

results. The performance of the INDICAIDTM COVID-19 Rapid Antigen At-Home 

Test was established in a prospective study using an EUA authorized molecular 

test as a comparator method (PPA 81.7% and NPA 99.4%). For more information 

on the performance of the test and how the performance may apply to you, 

please refer to the performance data in the Healthcare Provider Instructions for 

Use (IFU), available at www.indicaid.com. 

What if I have a positive test result?

A positive result means that, it is very likely that you have COVID-19 because 

proteins from the virus that causes COVID-19 were found in your sample. You 

should self-isolate from others and contact a healthcare provider for medical 

advice about your positive result. 

What if I have a negative test result?

A negative test result indicates that antigens from the virus that causes 

COVID-19 was not found in your sample. However, if you have symptoms of 

COVID-19, and your first test is negative, you should test again in 48 hours 

since antigen tests are not as sensitive as molecular tests. If you do not have 

symptoms and received a negative result, you should test at least two more 

times with 48 hours in between tests for a total of three tests. If you have a 

negative result, it does not rule out SARS-CoV-2 infection; you may still be 

infected and you may still infect others. It is important that you work with your 

healthcare provider to help you understand the next steps you should take. 

What does invalid test result mean?

If no control line shows up on the test, the result is invalid (even if any test 

line shows up). An invalid result means the test was not able to tell if you have 

COVID-19 or not. If the test is invalid, a new swab should be used to collect a 

new nasal specimen and you should test again with a new test. 

IMPORTANT 

Do not use this test as the only guide to manage your illness. Consult your 

healthcare provider if your symptoms persist or become more severe. 

Individuals should provide all results obtained with this product to their 

healthcare provider. 

STORAGE AND STABILITY 

Store the INDICAIDTM COVID-19 Rapid Antigen At-Home Test between 2-30°C 

(36-86°F) until use. Ensure all kit components are at room temperature before 

use. Kit contents are stable until the expiration date printed on the outer 

packaging. Do not use beyond the expiration date. For more information on 

expiration dating for COVID-19 antigen tests, please refer to 

http://www.fda.gov/covid-tests 

SUPPORT 

For questions, or to report a problem, please call +1 (877) 934-9344, or email 

care@indicaidusa.com or visit www.indicaid.com. Additional information is 

also available for you and your healthcare provider at www.indicaid.com. This 

user instructions, quick reference guide, fact sheet for healthcare provider and 

healthcare provider instructions for use are also available at 

www.indicaid.com. 

The INDICAIDTM COVID-19 Rapid Antigen At-Home Test Letter of Authorization, 

authorized fact sheets and authorized labeling are available on the FDA 

website and www.indicaid.com. 

EXPLANATION OF SYMBOLS 

In vitro diagnostic medical device Keep away from moisture 

Consult Instructions for use Do not reuse 

Caution—consult Catalog number accompanying documents 

30oC

2oC Temperature limit Batch code 

Keep away from sunlight Use-by date 

Contains sufficient for<n> tests Manufacturer 

PHASE Scientific International Limited

1/F, Building 22E, Phase 3, Hong Kong Science Park, 

Shatin, New Territories, Hong Kong 

Chemical Name GHS Code for each Ingredient Concentration 

TritonTM X-100 

H302, Harmful if swallowed 

H315, Skin irritation 

H318, Serious eye damage 

H410, Toxic to aquatic life 

0.1 % v/v1 

ProClinTM 300 

H302 + H332, Harmful if swallowed or if 

inhaled 

H314, Skin burns and eye damage 

H317, May cause an allergic skin reaction 

H410, Toxic to aquatic life 

0.3% v/v1 

1

 Chemical agent is not considered hazardous at this concentration. 
QUICK REFERENCE GUIDE 

COVID-19 Rapid Antigen 

At-Home Test

P0038, P0039, P0040, P0041 

30oC

2oC

Suitable for ages 2+ years 

Must be 14+ to use kit unsupervised 

Performing Your Test

1

Note: 

Your test kit box may contain 

more than one test kit 

INDICAID COVID-19 Rapid Antigen Test 

TEST DEVICE 

20 

mins 

HOW TO USE THIS TEST 

• Serial testing should be performed in all individuals with negative 

results; individuals with symptoms of COVID-19 and initial negative 

results should be tested again after 48 hours. Individuals without 

symptoms of COVID-19, and with initial negative results, should be 

tested again after 48 hours and, if the 2nd test is also negative, a 

3rd time after an additional 48 hours. You may need to purchase 

additional tests to perform this serial (repeat) testing. 

• If you test negative but continue to have symptoms of COVID-19, 

and both your first and second tests are negative, you may not have 

COVID-19, however you should follow-up with your healthcare provider. 

• If your test is positive, then proteins from the virus that causes 

COVID-19 have been found in your sample and you likely have 

COVID-19. 

20

SEC

2 3

Gather your supplies Wash your hands thoroughly Remove entire buffer 

• Check the expiration date on the for at least 20 seconds solution vial cap

outside of the product box. For before and after testing • Twist off the entire cap (purple 

more information on expiration & white parts together) from the 

dating for COVID-19 antigen tests, buffer solution vial. 

please refer to • Place vial and cap on a flat surface. http://www.fda.gov/covid-tests 

• Remove 1 swab, 1 test device Check the buffer solution volume 

pouch, and 1 buffer solution vial. in the vial. If the vial is empty, DO 

NOT use and obtain a new buffer • Make sure you have a timer (that solution vial. 

can time 20 minutes). The test kit 

does not come with one. 

Tilt x20

7

T

8

3 drops 

Release sample into buffer Cap the vial and expose Add buffer solution to test 

solution vial dropper tip device 

• Immediately place the nasal swab • Tightly cap the buffer solution vial • Open the test device pouch and 

into the buffer solution vial. Tilt with the vial cap. place the test device on a flat 

the vial to make sure that the • Remove the purple part of the cap surface. 

swab tip (soft end) is thoroughly from the vial to expose the dropper • Locate the sample well (S) on the 

soaked and immersed in the tip. test device. 

buffer solution. • Avoid touching the dropper tip • Slowly squeeze 3 drops of the 

• Twist the swab back and forth 20 with your finger. buffer solution into the sample 

times in the buffer solution. well. 

• Before taking out, press and roll the • False negative results may occur if 

swab tip against the inner wall of the less than 3 drops are applied to the 

vial to remove any excess solution. sample well. 

• Properly dispose of the used swab 

in a trash receptacle. 

Test samples immediately after 

collection, but no more than 5 

minutes after specimen collection 

before placement into extraction 

buffer or up to 2 hours after 

placement into extraction buffer, 

if kept at room temperature. 

WHAT YOU NEED TO KNOW BEFORE YOU START 

• This test aids in the clinical diagnosis of COVID-19, but it should not be the 

only guide to manage illness. Please consult a healthcare professional if your 

symptoms persist or worsen. 

• This test kit is for testing for current infection only and cannot tell if you have 

had a COVID-19 infection in the past. 

• You must follow the test directions carefully to get an accurate result. Read 

lay user instructions carefully before starting the test. 

• Make sure you have enough time to complete the entire testing process. It 

takes approximately 25 minutes to complete the process once you begin. 

• This kit should not be used on children under age 2. In children ages 2-13, the 

nasal swab sample must be collected and tested by an adult (18+ years old). 

• Always wear a protective mask or other face-covering when collecting nasal 

swab samples from anyone, whether a child or an adult. 

4

1⁄2 – 3⁄4 in 

5

x4 x4

Same 

Swab 

Remove nasal swab from 

its pouch 

• To keep the swab sterile, avoid 

touching the soft tip onto any 

surface. Only remove the swab 

from its pouch once the test is 

ready to be performed. 

9

20

mins

Let test device sit for 20 

minutes and read test result 

• Start a timer for 20 minutes. 

• Leave the test device on a table or 

flat surface until the timer goes off.

• Read your test results immediately 

at 20 minutes. 

Do NOT read the results before 20 

minutes or if it has been longer 

than 25 minutes from when the 

vial solution has been added to the 

sample well, as the test may have 

an inaccurate outcome. 

1st Nostril 

Swabbing the nostrils is 

critical for obtaining an 

accurate result. If you do 

not swab your nose, the 

test will produce a false 

negative result. 

2nd Nostril 

Collect nasal swab sample from both nostrils using same swab 

• Gently insert the swab tip into one nostril (no more than 1⁄2 to 3⁄4 inch). 

You do not need to go deep. Refer to diagram. 

• Using firm pressure, slowly rotate the swab in a circular path against the 

inside wall of the nostril. Make at least 4 big circles. Take approximately 15 

seconds to collect the specimen. Be sure to collect any nasal drainage that 

may be present on the swab. 

• Repeat in the second nostril using the same swab. 

• With children, the maximum depth of insertion into the nostril may be less 

than 3⁄4 of an inch, and you may need to have a second person hold the 

child’s head while swabbing. 

10

T

Dispose of used test kit 

materials 

• Dispose of all used test kit 

components and swab samples in 

a trash receptacle. 

• Do not flush or pour test liquids 

down the drain. 

Interpreting Your Results 

• Results should be considered in the context of an individual’s recent exposures, history, 

and the presence of clinical signs and symptoms consistent with COVID-19. 

• Read your results in a well-lit area. 

• Look for lines next to the ‘C’ (Control) and the ‘T’ (Test) areas on the test device. Use the 

information below to interpret what you see. 

• Report your test results to your healthcare provider to receive appropriate medical care. 

Status on First 

Day of Testing 

First Result 

Day 1 

Second Result 

Day 3 

Third Result 

Day 5 

Interpretation 

With 

Symptoms 

Positive 

Negative 

Negative 

N/A 

Positive 

Negative 

N/A 

N/A 

N/A 

Positive for COVID-19 

Positive for COVID-19 

Negative for COVID-19 

Without 

Symptoms 

Positive 

Negative 

Negative 

Negative 

N/A 

Positive 

Negative 

Negative 

N/A 

N/A 

Positive 

Negative 

Positive for COVID-19 

Positive for COVID-19 

Positive for COVID-19 

Negative for COVID-19 

POSITIVE TEST RESULT 

A positive test result means that the virus that causes COVID-19 was detected in your 

sample and it is very likely you have COVID-19 and are contagious. Please contact your 

doctor/primary care physician or your local health authority immediately and adhere to 

the local guidelines regarding self-isolation. There is a very small chance that this test 

can give a positive result that is incorrect (a false positive). Your healthcare provider will 

work with you to determine how best to care for you based on your test results along 

with medical history and your symptoms. 

If a control (C) line and a test (T) line are visible, the test is 

positive. Any faint visible red test (T) line with the control line 

C (C) should be read as positive. You do not need to perform 

+ 

T T or repeat testing if you have a positive result at any time. 

C

Look very closely! The color intensity in the 

“T” area can vary. Any faint line right next to 

the “T” should be considered positive. 

Take these next steps 

Please consult your healthcare provider to discuss your positive test result. You should 

self-isolate at home per CDC recommendations to stop spreading the virus to others. 

NEGATIVE TEST RESULT 

A negative test result indicates that antigens from the virus that causes COVID-19 were not 

detected in your sample. A negative result is presumptive, meaning it is not certain that 

you do not have COVID-19. You may still have COVID-19 and you may still be contagious. 

There is higher chance of false negative results with antigen tests than with laboratorybased molecular tests such as PCR. This means that there is higher chance this test will 

give you a negative result when you have COVID-19. If you test negative and continue to 

experience COVID-19 like symptoms of fever, cough, and/or shortness of breath you should 

seek follow up care with your healthcare provider. 

If the control (C) line is visible, but the test (T) line is not visible, 

the test is negative 

C

Take these next steps 

To increase the chance that the negative result for 

COVID-19 is accurate, you should: 

• Test again in 48 hours if you have symptoms on the 

first day of testing.

• Test 2 more times, at least 48 hours apart, if you do 

not have symptoms on the first day of testing.

• If you develop COVID-19 symptoms or your symptoms 

become severe, seek medical attention immediately. 

T

Report your test result(s) at MakeMyTestCount.Org – this voluntary and anonymous 

reporting helps public health teams understand COVID-19 spread in your area and 

across the country and informs public health decisions. 

INVALID TEST RESULT 

No red-colored line next to the “C” means the test is invalid. 

Re-test with a new swab and a new test device. 

C or TC

T If there is no red line next to the “C”, the 

result is invalid regardless of whether 

there is a red-colored line next to the “T”. 

Take these next steps 

Collect a new nasal swab sample and repeat the test with a new INDICAIDTM 

COVID-19 Rapid Antigen At-Home Test. If you develop COVID-19 symptoms or 

your symptoms become severe, seek medical attention immediately. 

PI-0001 (D) 

6

With 

Symptoms 

Without 

Symptoms 

With 

Symptoms 

Without 

Symptoms 

Without 

Symptoms 
EMERGENCY USE 

FDAAUTHORIZATION

Quick and Easy

P0038

IMPORTANT 

Positive Result 

Negative Result 

2 lines 

1 line 

Refer to detailed results explanation inside 

C T

C T

TEST WHEN... RESULTS 

COVID-19 symptoms

Self-quarantine

Travel decisions

School/Work decisions

Protect others

COVID-19 RAPID ANTIGEN AT-HOME TEST

Quick • Easy • Results in 20 minutes 

COVID-19

RAPID ANTIGEN AT-HOME TEST

• In the USA, this product has not been FDA cleared or approved; but has been authorized by FDA under an EUA • This product has 

been authorized only for the detection of proteins from SARS- CoV-2, not for any other viruses or pathogens • The emergency use of 

this product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency 

use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic 

Act, 21 U.S.C. §360bbb-3(b)(1), unless the declaration is terminated, or authorization is revoked sooner.

• For Emergency Use Authorization (EUA) only • For in vitro diagnostic use • Must be 2+ years to use this kit • Determining a negative 

result requires multiple tests • You may need to purchase additional tests to perform serial (repeat) testing • This test is more likely to 

give you a false negative result when you have COVID-19 than a lab-based molecular test • This test does NOT determine if you had 

COVID-19 in the past or if you have immunity.

OTC

User Instructions Individually Wrapped 

(2 Each) Test Devices 

T

Buffer Solution 

Vials (2 Each)

Individually Wrapped

Swabs (2 Each)

CONTAINED IN THIS BOX

A timer is required but not provided.

SIMPLE TO USE

Refer to detailed instructions inside.

The INDICAIDTM COVID-19 Rapid Antigen At-Home Test is a lateral flow immunoassay that uses 

antibodies to detect nucleocapsid protein from SARS-CoV-2 in anterior nasal swabs from 

those with symptoms of COVID-19 within the first 6 days of symptom onset when tested at 

least twice over three days with at least 48 hours between tests, or from those without 

symptoms or other epidemiological reasons to suspect COVID-19 when tested at least three 

times over five days with at least 48 hours between tests.

One-time use only

Read instructions

inside before use

For use with and 

without symptoms 

2

Store at 2°C – 30°C

(35.6°F – 86°F)

Use device with caution 

Suitable for ages 2+ years. 

Must be 14+ to use kit 

unsupervised

2+

Contains 2 tests

Keep away from 

sunlight 

Keep away from 

moisture

2

2

TESTS

PB-0015 (E)

PROTECT others

PROTECT yourself

PROTECT others

PROTECT yourself PROTECT othersPROTECT yourself

Manufacturer:

PHASE SCIENTIFIC INTERNATIONAL LTD.

1/F, Building 22E, Phase 3, Hong Kong Science Park,

Shatin, New Territories, Hong Kong

indicaid.com +1 (877) 934-9344 care@indicaidusa.com

For more information on expiration dating for COVID-19 antigen tests,

please refer to http://www.fda.gov/covid-tests

15 203 203 24.2 

25 18 65.8 25

25

Project: COVID-19 Rapid Antigen Test

Description: US OTC Box (2rxn)

Document Number: PB-0015 (E)

Size: L203xW25xH65 Unit: MM

Paper: 300gsm one side coat artboard

Last Update: 18 Nov 2022

Color: 4C+0C Finishing: Matt Lamination 
Quick • Easy • Results in 20 minutes 

COVID-19

RAPID ANTIGEN AT-HOME TEST

EMERGENCY USE 

FDAAUTHORIZATION

4

TESTS

IMPORTANT 

Positive Result 

Negative Result 

2 lines 

1 line 

Refer to detailed results explanation inside 

C T

C T

TEST WHEN... RESULTS 

COVID-19 symptoms

Self-quarantine

Travel decisions

School/Work decisions

Protect others

P0039

Manufacturer:

PHASE SCIENTIFIC INTERNATIONAL LTD.

1/F, Building 22E, Phase 3, Hong Kong Science Park,

Shatin, New Territories, Hong Kong

Quick and Easy

COVID-19 RAPID ANTIGEN AT-HOME TEST

•In the USA, this product has not been FDA cleared or approved; but has been authorized by FDA under an 

EUA • This product has been authorized only for the detection of proteins from SARS- CoV-2, not for any other 

viruses or pathogens • The emergency use of this product is only authorized for the duration of the declaration 

that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection 

and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. 

§360bbb-3(b)(1), unless the declaration is terminated, or authorization is revoked sooner.

• For Emergency Use Authorization (EUA) only • For in vitro diagnostic use • Must be 2+ years to use this kit

• Determining a negative result requires multiple tests • You may need to purchase additional tests to perform 

serial (repeat) testing • This test is more likely to give you a false negative result when you have COVID-19 than a 

lab-based molecular test • This test does NOT determine if you had COVID-19 in the past or if you have immunity.

The INDICAIDTM COVID-19 Rapid Antigen At-Home Test is a lateral flow immunoassay that uses 

antibodies to detect nucleocapsid protein from SARS-CoV-2 in anterior nasal swabs from 

those with symptoms of COVID-19 within the first 6 days of symptom onset when tested at 

least twice over three days with at least 48 hours between tests, or from those without 

symptoms or other epidemiological reasons to suspect COVID-19 when tested at least three 

times over five days with at least 48 hours between tests.

User Instructions Individually Wrapped 

(4 Each) Test Devices 

T

Buffer Solution 

Vials (4 Each)

Individually Wrapped

Swabs (4 Each)

CONTAINED IN THIS BOX

A timer is required but not provided.

SIMPLE TO USE

Refer to detailed instructions inside.

One-time use only 

Read instructions

inside before use

For use with and 

without symptoms 

2

Store at 2°C – 30°C

(35.6°F – 86°F)

Use device with caution 

Suitable for ages 2+ years. 

Must be 14+ to use kit 

unsupervised

2+

Contains 4 tests

Keep away from 

sunlight 

Keep away from 

moisture

4

PB-0016 (D)

PROTECT others

PROTECT yourself

PROTECT others

PROTECT yourself

PROTECT others

PROTECT yourself

OTC

indicaid.com +1 (877) 934-9344 care@indicaidusa.com

15 203 203 34.2 

35 18 65.8 35 

35 

Project: COVID-19 Rapid Antigen Test

Description: US OTC Box (4rxn)

Document Number: PB-0016 (D)

Size: L203xW35xH65 Unit: MM

Paper: 300gsm one side coat artboard

Last Update: 18 Nov 2022

Color: 4C+0C Finishing: Matt Lamination 

For more information on expiration dating for COVID-19 antigen tests,

please refer to http://www.fda.gov/covid-tests
PROTECT others

PROTECT yourself

PROTECT others

PROTECT yourself

IMPORTANT 

Positive Result 

Negative Result 

2 lines 

1 line 

Refer to detailed results explanation inside 

C T

C T

RESULTS 

COVID-19 RAPID ANTIGEN AT-HOME TEST

The INDICAIDTM COVID-19 Rapid Antigen At-Home Test is a 

lateral flow immunoassay that uses antibodies to detect 

nucleocapsid protein from SARS-CoV-2 in anterior nasal 

swabs from those with symptoms of COVID-19 within the 

first 6 days of symptom onset when tested at least twice 

over three days with at least 48 hours between tests, or 

from those without symptoms or other epidemiological 

reasons to suspect COVID-19 when tested at least three 

times over five days with at least 48 hours between tests.

SIMPLE TO USE Refer to detailed instructions inside.

12

TESTS

TEST WHEN... 

COVID-19 symptoms

Self-quarantine

Travel decisions

School/Work decisions

Protect others

T

Buffer Solution Vials

(12 Each)

Individually Wrapped 

Test Devices (12 Each)

Individually Wrapped 

Swabs (12 Each)

User Instructions 

CONTAINED IN THIS BOX A timer is required but not provided.

Quick • Easy • Results in 20 minutes 

COVID-19

RAPID ANTIGEN AT-HOME TEST

TESTS

12

EMERGENCY USE 

AUTHORIZATION ADF

•In the USA, this product has not been FDA cleared or approved; but has been authorized by FDA under an EUA • This product has been authorized only for the detection 

of proteins from SARS- CoV-2, not for any other viruses or pathogens • The emergency use of this product is only authorized for the duration of the declaration that 

circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the 

Federal Food, Drug and Cosmetic Act, 21 U.S.C. §360bbb-3(b)(1), unless the declaration is terminated, or authorization is revoked sooner.

•For Emergency Use Authorization (EUA) only •For in vitro diagnostic use •Must be 2+ years to use this kit • Determining a negative result requires 

multiple tests • You may need to purchase additional tests to perform serial (repeat) testing • This test is more likely to give you a false negative result 

when you have COVID-19 than a lab-based molecular test • This test does NOT determine if you had COVID-19 in the past or if you have immunity.

+1 (877) 934-9344

indicaid.com

care@indicaidusa.com

One-time use only

Read instructions

inside before use

For use with and 

without symptoms 

2

Store at 2°C – 30°C

(35.6°F – 86°F)

Use device with caution 

Suitable for ages 2+ years. 

Must be 14+ to use kit 

unsupervised

2+

Contains 12 tests

Keep away from 

sunlight 

Keep away from 

moisture

12

PB-0017 (D)

: Manufacturer

PHASE SCIENTIFIC INTERNATIONAL LTD.

1/F, Building 22E, Phase 3, Hong Kong Science Park,

Shatin, New Territories, Hong Kong

PROTECT others

PROTECT yourself

P0040

COVID-19 RAPID ANTIGEN AT-HOME TEST

90 22 65 63

18 203 90 203 90

Project: COVID-19 Rapid Antigen Test

Description: US OTC Box(12rxn)

Document Number: PB-0017 (D)

Size: L203xW90xH65 Unit: MM

Paper: 300gsm one side coat artboard

Last Update: 18 Nov 2022

Color: 4C+0C Finishing: Matt Lamination 

For more information on expiration dating for COVID-19 antigen tests,

please refer to http://www.fda.gov/covid-tests
Quick and Easy

Results in 20 minutes

24

TESTS

24

TESTS

IMPORTANT 

Positive Result 

Negative Result 

2 lines 

1 line 

Refer to detailed results explanation inside 

C T

C T

RESULTS 

COVID-19 RAPID ANTIGEN AT-HOME TEST COVID-19 RAPID ANTIGEN AT-HOME TEST

Individually Wrapped 

Swabs (24 Each)

Individually Wrapped User Instructions

Test Devices (24 Each)

Buffer Solution Vials

(24 Each)

T

CONTAINED IN THIS BOX A timer is required but not provided.

TEST WHEN... 

COVID-19 symptoms

Self-quarantine

Travel decisions

School/Work decisions

Protect others

EMERGENCY USE 

AUTHORIZATION ADF

The INDICAIDTM COVID-19 Rapid Antigen At-Home Test is a lateral flow 

immunoassay that uses antibodies to detect nucleocapsid protein from 

SARS-CoV-2 in anterior nasal swabs from those with symptoms of COVID-19 

within the first 6 days of symptom onset when tested at least twice over three 

days with at least 48 hours between tests, or from those without symptoms or 

other epidemiological reasons to suspect COVID-19 when tested at least three 

times over five days with at least 48 hours between tests.

SIMPLE TO USE Refer to detailed instructions inside.

•In the USA, this product has not been FDA cleared or approved; but has been authorized by FDA under an EUA •This product has been 

authorized only for the detection of proteins from SARS- CoV-2, not for any other viruses or pathogens •The emergency use of this 

product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use 

of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic 

Act, 21 U.S.C. §360bbb-3(b)(1), unless the declaration is terminated, or authorization is revoked sooner.

•For Emergency Use Authorization (EUA) only •For in vitro diagnostic use •Must be 2+ years to use this kit •Determining 

a negative result requires multiple tests • You may need to purchase additional tests to perform serial (repeat) testing 

• This test is more likely to give you a false negative result when you have COVID-19 than a lab-based molecular test 

• This test does NOT determine if you had COVID-19 in the past or if you have immunity.

care@indicaidusa.com +1 (877) 934-9344 indicaid.com

One-time use only

Read instructions

inside before use

For use with and 

without symptoms 

2

Store at 2°C – 30°C

(35.6°F – 86°F)

Use device with caution 

Suitable for ages 2+ years. 

Must be 14+ to use kit 

unsupervised

2+

Contains 24 tests

Keep away from 

sunlight 

Keep away from 

moisture

24

: Manufacturer

PHASE SCIENTIFIC INTERNATIONAL LTD.

1/F, Building 22E, Phase 3, Hong Kong Science Park,

Shatin, New Territories, Hong Kong

PB-0018 (D)

P0041

PROTECT others

PROTECT yourself

PROTECT others

PROTECT yourself

PROTECT others

PROTECT yourself

COVID-19

RAPID ANTIGEN AT-HOME TEST

18 225 165.8 225 165

166 25 108 80

Project: COVID-19 Rapid Antigen Test

Description: US OTC Box(24rxn)

Document Number: PB-0018 (D)

Size: L225xW166xH80 Unit: MM

Paper: 350gsm one side coat artboard

Last Update: 18 Nov 2022

Color: 4C+0C Finishing: Matt Lamination 

For more information on expiration dating for COVID-19 antigen tests,

please refer to http://www.fda.gov/covid-tests